Trehalose Treatment for Pre-eclampsia via Autophagy Restoration

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Pre-eclampsia, a serious pregnancy complication, is poorly understood in terms of mechanism and cause, and existing treatments are inadequate, particularly in addressing protein aggregation-related pathology.

Innovation Solution

Administering trehalose or its derivatives to treat or prevent pre-eclampsia by detecting tauopathy markers, such as cis-p-tau, and promoting the degradation of protein aggregates through autophagy restoration, thereby addressing the underlying protein aggregation mechanisms.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Reliability

If existing treatments are used for pre-eclampsia, then traditional management approaches are applied, but they are inadequate in addressing protein aggregation-related pathology

Engineering Contradiction:
Improvetreatment effectivenessVSAvoidability to address protein aggregation pathology
Core Design Contradiction:
ReliabilityVSAdaptability or versatility

Solution Approach 1:

The invention changes the biochemical parameters of the system by introducing trehalose, which modifies the molecular environment to promote protein aggregate degradation. This addresses the inadequacy of existing treatments by altering the chemical state of protein aggregates in pre-eclampsia patients, enabling effective treatment of protein aggregation-related pathology that traditional management approaches cannot address

Inventive Principle:
Principle #35Parameter changes

2Object-affected harmful factors

If trehalose is administered to promote degradation of protein aggregates, then protein aggregate levels are reduced and autophagy is restored, but the mechanism involves complex cellular processes

Engineering Contradiction:
Improveprotein aggregatesVSAvoidautophagy restoration mechanism
Core Design Contradiction:
Object-affected harmful factorsVSDevice complexity

Solution Approach 1:

The invention enables the cell's own autophagy machinery to serve itself by restoring its function through trehalose administration. The autophagy system, which is naturally present in cells, is reactivated to degrade protein aggregates without requiring external complex intervention mechanisms. This simplifies the approach by leveraging the body's inherent self-cleaning capabilities rather than introducing complex external degradation systems

Inventive Principle:
Principle #25Self-service

Applied Scientific Principles

This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.

Function Achieved in This Case

Trehalose effectively treats and prevents pre-eclampsia by reducing protein aggregates and restoring autophagy machinery, as demonstrated in both cellular and animal models, offering a novel approach to managing this condition.

Implementation Method 1

promoting the degradation of protein aggregates through autophagy restoration

Methodology Applied
Scientific EffectAutophagy:

Data Source

PatentUS11844808B2Methods and compositions for treating pre-eclampsia
Publication Date: 2023.12.19 WOMEN & INFANTS HOSPITAL OF RHODE ISLAND
  • US11844808B2 patent drawing
  • US11844808B2 patent drawing
  • US11844808B2 patent drawing

AI summary

Methods and compositions using trehalose or a derivative or prodrug thereof for treating pre-eclampsia in a subject are disclosed.